Published in Cancer Chemother Rep on July 06, 1976
Cancer immunotherapy. Can Med Assoc J (1979) 1.54
A preliminary study of intravenous methanol extraction residue of BCG in treatment of advanced cancer. Br J Cancer (1977) 0.75
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology (1977) 2.55
First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol (2001) 2.44
Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells. Radiology (1975) 1.90
Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials. Br J Radiol (1974) 1.87
History of lactation and breast cancer risk. Am J Epidemiol (1993) 1.52
Undergoing cardiac catheterization: the effects of informational preparation and coping style on patient anxiety during the procedure. Heart Lung (1994) 1.48
Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med (1970) 1.46
Cervical cytology screening. How can we improve rates among First Nations women in urban British Columbia? Can Fam Physician (1996) 1.44
Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer Suppl (1978) 1.42
Participation in the British Columbia Cervical Cytology Screening Programme by Native Indian women. Can J Public Health (1993) 1.36
Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys (1986) 1.32
Mortality and cancer incidence in aluminum reduction plant workers. J Occup Med (1991) 1.31
Barriers to cervical cytology screening in native women in British Columbia. Cancer Detect Prev (1992) 1.31
The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol (1978) 1.31
First analysis of mortality and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol (1998) 1.29
Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial. Cancer (1982) 1.27
Multiple myeloma, leukemia, and cancer of the ovary in cosmetologists and hairdressers. Am J Ind Med (1984) 1.25
A novel technique for measuring human tissue pO2 at the cellular level. Br J Cancer (1986) 1.21
Occupational mortality patterns among British Columbia farm workers. J Occup Med (1984) 1.17
The incidence of cervical cancer among Chinese and Caucasians in British Columbia. Can J Public Health (1993) 1.16
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer (1976) 1.14
Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme. J Clin Oncol (2000) 1.09
Radiobiological characterization of the inactivating events produced in mammalian cells by helium and heavy ions. Int J Radiat Oncol Biol Phys (1977) 1.08
Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer. Cancer Treat Rep (1976) 1.02
Accidental and intentional violent deaths among British Columbia native Indians. Can J Public Health (1987) 1.01
Cancer and aplastic anemia in British Columbia farmers. J Natl Cancer Inst (1984) 0.99
Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study. Br J Cancer (1992) 0.97
Imaging tumor hypoxia and tumor perfusion. J Nucl Med (1993) 0.94
Inferior ST segment depression during acute anterior myocardial infarction: clinical and angiographic correlations. J Am Coll Cardiol (1984) 0.94
Cervical cancer screening in Canadian Native women. Adequacy of the Papanicolaou smear. Acta Cytol (1994) 0.94
Radiotherapy pilot trials with sensitizers of hypoxic cells: metronidazole in supratentorial glioblastomas. Br J Radiol (1977) 0.93
Growth rate of pulmonary metastases in human sarcomas. Cancer (1975) 0.93
The application in radiation therapy of substances which modify cellular radiation response. Cancer (1977) 0.91
Assessment of adult cancer pain: shortcomings of current methods. Pain (1988) 0.91
Tamoxifen-induced tumor stimulation and withdrawal response. Cancer Treat Rep (1980) 0.90
Radiosensitivity testing of human primary brain tumor specimens. Int J Radiat Oncol Biol Phys (1992) 0.90
Influence of estrogen receptor status on dietary risk factors for breast cancer. CMAJ (1988) 0.90
Phase I toxicologic study of Lonidamine in cancer patients. Oncology (1984) 0.89
Differences in incidence rates of cancers of the respiratory tract by anatomic subsite and histologic type: an etiologic implication. J Natl Cancer Inst (1989) 0.89
Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol (1990) 0.89
Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control (1992) 0.89
Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study. Cancer Treat Rep (1986) 0.89
High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity. Int J Radiat Oncol Biol Phys (1982) 0.88
Cardiac amyloidosis: combined use of two-dimensional echocardiography and electrocardiography in noninvasive screening before biopsy. Clin Cardiol (1985) 0.88
Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer. J Natl Cancer Inst (1992) 0.87
Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study. Cancer Treat Rep (1986) 0.87
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03. Int J Radiat Oncol Biol Phys (1990) 0.87
Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer (1985) 0.86
Occupation and risk of cutaneous melanoma. Am J Ind Med (1986) 0.86
Misonidazole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys (1984) 0.86
Reducing cervical cancer among First Nations women. Can Nurse (1998) 0.84
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile. Cancer Res (1987) 0.84
Circulatory changes in severe aortic regurgitation before and after surgical correction. Am J Cardiol (1971) 0.84
Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial. J Neurosurg (1989) 0.84
Reversibility of bronchial marked atypia: implication for chemoprevention. Cancer Detect Prev (1986) 0.84
Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508. Int J Radiat Oncol Biol Phys (1984) 0.83
High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer. Cancer Treat Rep (1981) 0.83
Conjugation of coxsackievirus type B1-B6 immunoglobulins with fluorescein isothiocyanate by a "reversed" dialysis method. J Infect Dis (1978) 0.82
The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine. J Pain Symptom Manage (1992) 0.82
Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol (1987) 0.82
Cancer mortality experience of woodworkers, loggers, fishermen, farmers, and miners in British Columbia. Natl Cancer Inst Monogr (1985) 0.82
Treatment of central nervous system leukemia with intrathecal cytosine arabinoside. Cancer (1973) 0.82
Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells. J Neurooncol (1991) 0.82
Initial pharmacology and toxicology of intravenous desmethylmisonidazole. Int J Radiat Oncol Biol Phys (1982) 0.81
Pharmacokinetic interaction of BCNU and misonidazole in humans. Int J Radiat Oncol Biol Phys (1982) 0.81
Occupational mortality among bartenders and waiters. Can J Public Health (1988) 0.81
Cytotoxic and radiosensitizing effects of misonidazole on hematopoiesis in normal and tumor-bearing mice. Int J Radiat Oncol Biol Phys (1980) 0.81
Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward? Int J Radiat Oncol Biol Phys (1984) 0.81
Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome. Cancer Treat Rep (1983) 0.80
Reproductive variables as possible confounders in occupational studies of breast and ovarian cancer in females. J Occup Med (1985) 0.80
Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy. Int J Radiat Oncol Biol Phys (1988) 0.80
Occupational risk factors for prostate cancer mortality in British Columbia, Canada. Am J Ind Med (1999) 0.80
Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule. Int J Radiat Oncol Biol Phys (1986) 0.80
The effect of radiation on normal human CNS as detected by NMR spectroscopy. Int J Radiat Oncol Biol Phys (1993) 0.80
Pharmacokinetics of Lonidamine after oral administration in cancer patients. Oncology (1984) 0.79
Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells. Int J Radiat Oncol Biol Phys (1992) 0.79
Gastric cancer and lymphosarcoma among wood and pulp workers. J Occup Med (1986) 0.79
Mortality among British Columbia pilots. Aviat Space Environ Med (1991) 0.79
In vivo studies of x-irradiation damage and repair in mammalian tumor cells. Radiology (1972) 0.79
New side effect of the hypoxic cell sensitizer, misonidazole. Cancer Treat Rep (1979) 0.79
Mortality among female registered nurses and school teachers in British Columbia. Am J Ind Med (1994) 0.79
Preparing adult patients for cardiac catheterization: informational treatment and coping style interactions. Heart Lung (1994) 0.79
Significance of precordial ST-segment depression in acute transmural inferior infarction: coronary angiographic findings. Cathet Cardiovasc Diagn (1983) 0.79
Treatment of infiltrating bladder cancer by cobalt 60 radiation: recurrence of tumor in bladder after initial disappearance. J Urol (1969) 0.79
Mining, lung cancer and smoking. Scand J Work Environ Health (1980) 0.79
Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancer. Ann Oncol (1992) 0.79
Hemodynamic changes following correction of severe aortic stenosis using the Cutter-Smeloff prosthesis. Circulation (1970) 0.79
Hypoxic cell sensitizers and heavy charged-particle radiations. Br J Cancer Suppl (1978) 0.79
A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancer. Breast Cancer Res Treat (1981) 0.78
Myocardial protection during aortic valve replacement: normothermia versus hypothermia. Can J Surg (1978) 0.78
Occupational electromagnetic field exposure, solvent exposure, and leukemia. J Occup Med (1990) 0.78
High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens. Can Med Assoc J (1973) 0.78
Radiation plus metronidazole for glioblastoma. N Engl J Med (1977) 0.78
Occupational associations among British Columbia male cancer patients. Can J Public Health (1990) 0.78
Clinical determinants of mammographic dysplasia patterns. Cancer Detect Prev (1996) 0.78
Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study. J Neurooncol (1992) 0.77